Clinical Trial Update: Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment [Phase 3]

View source ↗

Summary

This document reports the completion and posting of results from a Phase 3 safety study of HZT-501 in patients who require long-term NSAID treatment for osteoar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome
• Low Back Pain
• Osteoarthritis
• Rheumatoid Arthritis
• Soft Tissue Pain

Drugs mentioned

• HZT-501

Snippet

Sponsor: Amgen | Conditions: Osteoarthritis, Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-25